Standard NHS panels are designed to identify serious pathology. They use population-derived reference ranges that include unwell people. Between "nothing serious found" and "actually well" lies a functional territory that functional blood chemistry interpretation reveals — insulin resistance, subclinical hypothyroidism, early inflammation, and nutrient insufficiency invisible to standard analysis.
The NHS standard blood panel is one of the most efficient diagnostic tools in primary care. A full blood count, basic metabolic panel, liver function tests, thyroid screen, and lipid panel can collectively identify anaemia, kidney disease, liver pathology, diabetes, hypothyroidism, and dyslipidaemia from a single blood draw. For detecting serious illness at the pathological level, it is genuinely excellent.
But the reference ranges it uses are population-derived — calculated from the distribution of results in the tested population, including people who are unwell, medicated, or metabolically compromised. A result within the "normal" range means you are within the range seen in that population. It does not mean you are at the level where physiology functions optimally. These are fundamentally different statements, and confusing them is the source of enormous clinical under-detection.
Consider TSH. The NHS normal range is 0.5–4.5 mIU/L. A result of 4.2 is reported as normal and the patient is told their thyroid is fine. Functionally, a TSH of 4.2 is not fine — it indicates the pituitary is working hard to stimulate a thyroid gland that is not producing enough hormone. Symptoms of fatigue, weight gain, cold intolerance, dry skin, and cognitive fog are consistent with subclinical hypothyroidism in the upper half of the “normal” range. The functional optimal is 1.0–2.0 mIU/L.
| Marker | Lab Normal | Functional Optimal | Clinical Significance of Gap |
|---|---|---|---|
| TSH | 0.5–4.5 mIU/L | 1.0–2.0 mIU/L | TSH 3.0–4.5 = subclinical hypothyroid territory |
| Ferritin | 12–300 ng/mL | 70–150 ng/mL | Below 50 = tissue iron depletion; hair, energy, thyroid affected |
| Vitamin D | >50 nmol/L sufficient | 125–175 nmol/L | 60 nmol/L is “sufficient” but well below immune-optimal |
| Fasting glucose | 3.9–5.5 mmol/L | 4.2–4.8 mmol/L | 5.2 mmol/L is “normal” but rising insulin resistance |
| hsCRP | <10 mg/L (standard CRP) | <0.5 mg/L | CRP of 3 mg/L is “normal”; hsCRP shows significant inflammation |
| Homocysteine | 5–15 µmol/L | <8 µmol/L | 12 µmol/L is “normal” but doubles cardiovascular and dementia risk |
| B12 | 200–900 pg/mL | 600–1000 pg/mL | 350 pg/mL is “normal”; neurological and methylation insufficiency |
Insulin resistance is the underlying driver of type 2 diabetes, metabolic syndrome, PCOS, non-alcoholic fatty liver disease, cardiovascular disease, and increasingly Alzheimer’s disease. It develops over 10–20 years before HbA1c rises above diagnostic thresholds. During those years, fasting glucose and HbA1c may be completely normal while insulin resistance is already causing measurable damage.
The standard NHS panel does not include fasting insulin. Without fasting insulin, HOMA-IR (the insulin resistance index) cannot be calculated. Without HOMA-IR, insulin resistance is invisible in the blood work — until it isn’t, and HbA1c has crossed 48 mmol/mol and the diagnosis is type 2 diabetes.
The TG:HDL ratio (triglycerides divided by HDL cholesterol) is a surrogate marker for insulin resistance and small dense LDL particle predominance — both available from standard lipid panels. A TG:HDL ratio above 1.0 (in UK mmol/L units) suggests developing insulin resistance even when fasting glucose and HbA1c are normal. This is information already in the standard blood test that is rarely interpreted this way.
The NHS blood panel is an excellent screen for serious pathology. It was never designed to detect the early-stage functional dysregulation that precedes that pathology by years. That is not its failure — it is simply not the question it was built to answer.
The Randox Signature panel and Regenerus comprehensive blood chemistry provide the full functional picture: fasting insulin, HOMA-IR, hs-CRP, homocysteine, Lp(a), free T3 and T4, vitamin D at accurate 25-OH level, ferritin with functional interpretation, RBC magnesium, NLR, and the full lipid fractionation. These are not exotic tests — they are standard markers interpreted through a functional lens and measured with appropriate sensitivity. The Randox Everyman and Everywoman panels provide a solid foundation; functional interpretation by a practitioner trained in optimal rather than pathological reference ranges is what turns that data into clinical action.
The DH TDG Five-Test Programme investigates the territory that standard investigation doesn’t reach. Ask the Concierge which tests apply to your situation.
Ask the Concierge → See the TDG Programme